Q/C Technologies Inc.

Last updated September 27, 2026

Organization details

Legal name
Q/C Technologies Inc.
Former names
TNF Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. Akers Biosciences, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2835 — In Vitro & In Vivo Diagnostic Substances
Jurisdiction of incorporation
Delaware
Headquarters city
New York
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
December
Ticker symbol
QCLS
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001321834

Board of directors

Director election results

Annual meeting of June 3, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 11 other boards. 5 are in the same sector.

Network of Q/C Technologies Inc.'s board connections Tao Synergies Inc. Tao Synergies Inc. Telomir Pharmaceuticals Inc. Telomir Pharmaceutical... Fabric.AI Inc. Fabric.AI Inc. Femasys Inc. Femasys Inc. MIRA Pharmaceuticals Inc. MIRA Pharmaceuticals I... OS Therapies Incorporated OS Therapies Incorpora... PharmaCyte Biotech Inc. PharmaCyte Biotech Inc... RRE Ventures Acquisition Corp. RRE Ventures Acquisiti... Sono Group N.V. Sono Group N.V. Wrap Technologies Inc. Wrap Technologies Inc. XWELL Inc. XWELL Inc. Bruce Bernstein Bruce Bernstein Christopher C. Chapman Jr. Christopher C. Chapm... Christopher C. Schreiber Christopher C. Schre... Craig Eagle Craig Eagle Joshua Silverman Joshua Silverman Q/C Technologies Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$5,522
1 purchase by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 1, 2026 Joshua Silverman Director, Officer (Executive Chairman) Grant or award +77,390 — —
Jul 10, 2026 Joshua Silverman Director, Officer (Executive Chairman) Grant or award +16,620 — —
Apr 13, 2026 Joshua Silverman Director, Officer (Executive Chairman) Grant or award +162,162 — —
Mar 30, 2026 Chelsea Sierra Voss Director Open-market purchase +1,753 $3.15 $5,522
Jan 16, 2026 Chelsea Sierra Voss Director Grant or award +212,500 — —
Jan 16, 2026 Chelsea Sierra Voss Director Grant or award +25,000 — —
Nov 14, 2025 Mitchell Glass Director, Officer (Director, Chief Medical Off.) Grant or award +11,420 — —
Nov 14, 2025 Billy Joe White Director Grant or award +22,839 — —
Nov 14, 2025 Joshua Silverman Director, Officer (Executive Chairman) Grant or award +91,356 — —
Nov 14, 2025 Stephen Friscia Director Grant or award +22,839 — —
Nov 14, 2025 Bruce Bernstein Director Grant or award +25,000 — —
Nov 14, 2025 RAUCH GARY M Vice President of Finance Grant or award +11,420 — —
Oct 3, 2025 Billy Joe White Director Grant or award +2,161 — —
Oct 3, 2025 RAUCH GARY M Vice President of Finance Grant or award +1,080 — —
Oct 3, 2025 Joshua Silverman Director, Officer (Executive Chairman) Grant or award +8,644 — —

Organizations in the same sector, closest in location and size first.

Questions about Q/C Technologies Inc.

How many directors are on Q/C Technologies Inc.'s board?

Q/C Technologies Inc.'s board has 10 directors: Billy Joe White, Bruce Bernstein, Chelsea Sierra Voss, Christopher C. Chapman Jr., Christopher C. Schreiber, Craig Eagle, Joshua Silverman, Jude Uzonwanne, Mitchell Glass and Stephen Friscia.

Are Q/C Technologies Inc. insiders buying or selling shares?

Over the last 12 months, Q/C Technologies Inc. insiders bought $5,522 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="qc-technologies-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.